BABIO Introduces EV71-IgM Rapid Test for Early HFMD Diagnosis
Shandong, China – BABIO, a leading Chinese manufacturer of advanced in-vitro diagnostic solutions, has launched its Enterovirus 71 (EV71)-IgM Detection Kit (Colloidal Gold Method), designed for fast, accurate, and reliable detection of EV71 IgM antibodies in serum, plasma, or whole blood.
Enterovirus 71 (EV71) is one of the major causative agents of hand, foot, and mouth disease (HFMD), particularly in children, and can lead to serious neurological complications. Early detection is critical for effective patient management and outbreak control.
This lateral flow immunoassay delivers results in just 15 minutes, making it an ideal screening tool for hospitals, clinics, laboratories, and public health agencies across Europe, the Americas, Africa, and Southeast Asia. The kit is easy to use, requires no special equipment, and maintains high sensitivity and specificity.
Key features include:
-
Rapid results in 15 minutes
-
Shelf life of 2 years, stored at 2–30°C
-
Portable and stable for diverse climates
-
User-friendly for both clinical and field use
As a trusted name in global diagnostics, BABIO continues to innovate in infectious disease testing, supporting public health worldwide.
For more information on the EV71-IgM Detection Kit, visit our official website: https://www.babiocorp.com
#EV71Test #HFMDDetection #RapidTestKit #BABIO #InfectiousDisease #ColloidalGoldTest #PublicHealth